Last updated on February 2018

Rectal Bacteriotherapy Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Clostridium difficile
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Age 18 years
  • Verified recurrent CDI with symptoms of CDI and microbiological verification (PCR).
  • Previously treated for CDI with at least 10 days of vancomycin or metronidazole.
  • Be able to read and understand Danish.

Exclusion Criteria:

  • Life expectancy < 3 months.
  • Allergy toward vancomycin
  • Other infection in the GI tract with clinical symptoms similar to CDI.
  • Other illness in the GI tract with clinical symptoms similar to CDI.
  • Use of antibiotics for more than 14 days treating other infections
  • Planning pregnancy, pregnancy or breast feeding.
  • Severe immune suppression which makes FMT/RBT relatively contraindicated

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.